ATRION Financial Statements From 2010 to 2024

ATRION financial statements provide useful quarterly and yearly information to potential ATRION investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ATRION financial statements helps investors assess ATRION's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ATRION's valuation are summarized below:
ATRION does not now have any fundamental signals for analysis.
Check ATRION financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ATRION's main balance sheet or income statement drivers, such as , as well as many indicators such as . ATRION financial statements analysis is a perfect complement when working with ATRION Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

ATRION Company Current Valuation Analysis

ATRION's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current ATRION Current Valuation

    
  809.44 M  
Most of ATRION's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATRION is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, ATRION has a Current Valuation of 809.44 M. This is 94.36% lower than that of the Health Care Equipment & Supplies sector and 91.15% lower than that of the Health Care industry. The current valuation for all United States stocks is 95.13% higher than that of the company.

ATRION Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ATRION's current stock value. Our valuation model uses many indicators to compare ATRION value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATRION competition to find correlations between indicators driving ATRION's intrinsic value. More Info.
ATRION is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about  0.76  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ATRION is roughly  1.32 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATRION's earnings, one of the primary drivers of an investment's value.

About ATRION Financial Statements

Investors use fundamental indicators, such as ATRION's revenue or net income, to determine how well the company is positioned to perform in the future. Although ATRION's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas. Atrion Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 667 people.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in ATRION Stock

If you are still planning to invest in ATRION check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATRION's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities